Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-034-6 | CAS number: 7417-99-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Skin irritation. Key study. Method according to OECD guideline 439, GLP study. The test item is not a skin irrtant (no category) since the mean percent viability of the treated tissues was 93.1% in a RHE test.
Eye irritation.Key study.Method according to OECD guideline 437, GLP study. The test item is not irritating to the eye (no category) since IVIS score was found to be -1.53.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 December 2017 - 16 December 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Remarks:
- SkinEthic RHE® model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: foreskin (number of donors not specified)
- Source strain:
- not specified
- Justification for test system used:
- This study makes use of reconstructed human epidermis (RhE) (obtained from human derived non-transformed epidermal keratinocytes) which closely mimics the histological, morphological, biochemical and physiological properties of the upper parts of the human skin, i.e., the epidermis. Use of reconstructed human epidermis (RhE) is also recommended by OECD and other regulatory authorities. SkinEthicTM RHE model has been validated and is part of OECD validated reference methods (VRMs) and is also a recommended model for conducting in vitro skin irritation studies.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: SkinEthic RHE® model
- Tissue batch number(s): 17-RHE-127
- Production date:
- Shipping date:
- Delivery date:
- Date of initiation of testing: 12/12/2017
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation (if applicable): 37ºC
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: 25 x 1 mL of DPBS
- Observable damage in the tissue due to washing: no
- Modifications to validated SOP: no
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 300 µL of a MTT solution at 1.0 mg/mL
- Incubation time: 3 hours at 37°C, 5% CO2
- Spectrophotometer: Synergy™ microplate reader (BioTek)
- Wavelength: 570 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: 1.1 (CV = 4.5%) specification OD > 0.7. Historical negative control mean OD range = 1.964-2.776.
- Barrier function: 4.5 h (Specification 4h < ET50< 10h)
- Morphology: 6 Cell layers, absence of significant histological abnormalities, well differentiated epidermis, specification > 4
- Contamination: no
NUMBER OF REPLICATE TISSUES: 3
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE: no interference.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the tissue viability after 42 minutes exposure is less than or equal to 50%.
- The test substance is considered to be non-irritant to skin if the tissue viability after 42 minutes exposure is greater than 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 16 mg (32mg/cm2)
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 16 µL
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 16 µL
- Concentration (if solution): 5% SDS - Duration of treatment / exposure:
- 42 minutes
- Duration of post-treatment incubation (if applicable):
- 42 hours ± 60 minutes
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- mean
- Value:
- 93.1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- (DPBS)
- Positive controls validity:
- valid
- Remarks:
- 1.2% viability (5% SDS)
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: no
- Direct-MTT reduction: no
- Colour interference with MTT: no
DEMONSTRATION OF TECHNICAL PROFICIENCY: yes. A full demonstration of proficiency was performed for the EpiSkin-SM model, plus a reduced validation with the SkinEthic RHE model. Adequate results were obtained for the evaluated chemicals.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, SD of the negative control group was 0.03% (acceptablility criteria, SD ≤ 18%) and OD mean is 2.002 (acceptability criteria, 0.8≤OD≤3).
- Acceptance criteria met for positive control: yes, SD of the positive control group was 0.06% (acceptablility criteria, SD ≤ 18%)
- Acceptance criteria met for variability between replicate measurements: yes. SD of test item was 1.21% (acceptablility criteria, SD ≤ 18%). - Interpretation of results:
- other: No category (CLP Regulation EC no. 1272/2008)
- Conclusions:
- The test substance was found to not be a skin irritant in a reconstructed human epidermis test.
- Executive summary:
An in vitro skin irritation test of the test item was performed in a reconstructed human SkinEthic RHE® model, according to OECD TG 439 (GLP study). Three epidermis units were treated with 16 mg test item for 42 minutes at room temperature. Exposure of the test item was terminated by rinsing with 25 x 1 mL of DPBS. The epidermis units were then incubated at 37°C for 42 hours in an incubator with 5% CO2. The viability of each disk was assessed by incubating the tissues with MTT, extracting the precipitated formazan crystals using isopropanol and incubating the tissues for overnight in a refrigerator protected from light, and finally measuring the concentration of formazan by determining the OD at 570 nm. Under the test conditions, the mean percent viability of the treated tissues was 93.1%, versus 1.2% of the positive control (5% Sodium Dodecyl Sulfate). Therefore, the test item must be considered as not classified for skin irritation.
Reference
Table 1: Data Summary of Percent Viability
Treatment |
Tissue Replicate |
O.D. at 570 nm |
Blank Corrected O.D. |
Mean of Corrected O.D. |
Mean O.D. of Three Tissues |
% Viability/ Tissue |
Mean % Viability |
S.D. of % Viability |
C.V. of % Viability |
Corrosivity Class |
Negative Control (Dulbecco’s Phosphate Buffered Saline (DPBS)) |
1 |
2.067 |
2.026 |
2.004 |
2.002 |
100 |
100 |
0.03 |
1.50 |
NA |
2.017 |
1.976 |
|||||||||
2.051 |
2.010 |
|||||||||
2 |
2.021 |
1.980 |
1.988 |
|||||||
2.033 |
1.992 |
|||||||||
2.034 |
1.993 |
|||||||||
3 |
2.019 |
1.978 |
2.014 |
|||||||
2.105 |
2.064 |
|||||||||
2.042 |
2.001 |
|||||||||
N,N’-(Methylenedi-P-Phenylene)Bis(Aziridine-1-Carboxamide) (Poly-U-01) |
1 |
1.947 |
1.906 |
1.889 |
1.864 |
94.4 |
93.1 |
1.21 |
1.30 |
No Category |
1.910 |
1.869 |
|||||||||
1.932 |
1.891 |
|||||||||
2 |
1.847 |
1.806 |
1.842 |
92.0 |
||||||
1.896 |
1.855 |
|||||||||
1.905 |
1.864 |
|||||||||
3 |
1.900 |
1.859 |
1.861 |
93.0 |
||||||
1.895 |
1.854 |
|||||||||
1.910 |
1.869 |
|||||||||
Positive control (Sodium dodecyl sulphate (5% aq.)) |
1 |
0.068 |
0.027 |
0.026 |
0.025 |
1.3 |
1.2 |
0.06 |
5.00 |
Category 2 |
0.067 |
0.026 |
|||||||||
0.066 |
0.025 |
|||||||||
2 |
0.067 |
0.026 |
0.025 |
1.2 |
||||||
0.065 |
0.024 |
|||||||||
0.066 |
0.025 |
|||||||||
3 |
0.066 |
0.025 |
0.025 |
1.2 |
||||||
0.065 |
0.024 |
|||||||||
0.066 |
0.025 |
Key: O.D. = Optical density, S.D. = Standard deviation, C.V. = Coefficient of variation, NA = Not applicable
Note: For Negative control SD and CV of % viability was calculated using OD at 570 nm and for test item and positive control SD and CV of % viability was calculated using % viability/tissue.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 December 2017 - 30 December 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: Deonar Abattoir slaughter house, Mumbai, Maharashtra.
- Characteristics of donor animals (e.g. age, sex, weight): 1-5 years of age.
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions): transported under cold condition in Hank's Balanced Salt Solution containing antibiotics (penicillin at 100 IU/mL and streptomycin at 100 μg/mL).
- Time interval prior to initiating testing: eyes were used within 24 h from the slaughtering.
- indication of any existing defects or lesions in ocular tissue samples: Eyes were examined prior to use. Corneas from eyes free of visible defects were used.
- Indication of any antibiotics used: yes, penicillin at 100 IU/mL and streptomycin at 100 μg/mL. - Vehicle:
- other: corn oil
- Controls:
- yes, concurrent vehicle
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 750 μL
- Concentration (if solution): 20% (w/v).
VEHICLE
- Amount(s) applied (volume or weight with unit): 750 μL
- Concentration (if solution): not applicable
- Lot/batch no. (if required): MKBZ9899V (Sigma Aldrich) - Duration of treatment / exposure:
- 4 h ± 5 min
- Number of animals or in vitro replicates:
- 3 replicates.
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAS: All eyes were examined prior to use, corneas free from defects were dissected to a 2-3 mm rim and transferred to a container with Hank's Balanced Salt Solution. Corneas from eyes free of visible defects and with an opacity value inferior than 7 were used. The selected corneas were mounted on the corneal holders with the endothelial side against the O-ring of the posterior half of the holder, the anterior half of the holder was then placed on top of the cornea and fixed with screws. Both chambers were filled with pre-warmed phenol red free Eagle's Minimum Essential Medium (EMEM) and equilibrated at 32 ± 1ºC for at least 1h. Following the equilibration period, the medium was removed from both chambers and baseline opacity readings were taken for each cornea.
QUALITY CHECK OF THE ISOLATED CORNEAS: Corneas from eyes free of visible defects and with an opacity value inferior than 7 were used
NUMBER OF REPLICATES: 3
NEGATIVE CONTROL USED: yes. Normal saline (Sodium Chloride Injection I.P.), source: Realcade Life Sciences Pvt. Ltd., batch no: R2010266.
SOLVENT CONTROL USED: yes. Corn oil, source: Sigma Aldrich, batch no: MKBZ9899V.
POSITIVE CONTROL USED: yes. Imidazole (20% w/v solution), source: Sigma Aldrich, batch no: SLBP2962V.
APPLICATION DOSE AND EXPOSURE TIME: 750 μL of 20% (w/v) test item solution in corn oil, 4h exposure.
TREATMENT METHOD: closed chamber.
POST-INCUBATION PERIOD: no.
REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: the corneal epithelium was washed until no visual evidence of test item was observed using EMEM (containing phenol red) and, once the medium was free of test item, a final rinse with phenol red-free EMEM was performed.
- POST-EXPOSURE INCUBATION: no.
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: corneal opacity was measured with an opacitometer BASF-OP3.0 (Duratec, Germany)
- Corneal permeability: passage of sodium fluorescein dye measured with the aid of microtiter plate reader (OD490)
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
DECISION CRITERIA: as indicated in the TG (see table below). - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- mean
- Value:
- -1.53
- Vehicle controls validity:
- valid
- Remarks:
- 1.63
- Negative controls validity:
- valid
- Remarks:
- 1.32
- Positive controls validity:
- valid
- Remarks:
- 118.42
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- mean
- Value:
- -1.45
- Vehicle controls validity:
- valid
- Remarks:
- 1.41
- Negative controls validity:
- valid
- Remarks:
- 1.19
- Positive controls validity:
- valid
- Remarks:
- 88.24
- Irritation parameter:
- other: permeability
- Run / experiment:
- mean
- Value:
- -0.005
- Vehicle controls validity:
- valid
- Remarks:
- 0.014
- Negative controls validity:
- valid
- Remarks:
- 0.009
- Positive controls validity:
- valid
- Remarks:
- 2.012
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no.
DEMONSTRATION OF TECHNICAL PROFICIENCY: yes
ACCEPTANCE OF RESULTS:
- A test is considered acceptable if: the positive control gives an IVIS that falls within two standard deviations of the current historical mean and negative/solvent controls gives values of opacity and permeability lower than upper limits for background values.
- Acceptance criteria met for negative/solvent controls: yes (negative: opacity upper limit=2.52, permeability upper limit=0.099; solvent: permeability upper limit=0.065)
- Acceptance criteria met for positive control: yes (historical value range: 63.28 - 257.23, SD: 56.79; mean = 159.82, 2*SD = 113.57) - Interpretation of results:
- other: Not classified (CLP Regulation EC no. 1272/2008)
- Conclusions:
- The mean IVIS score for the test item was found to be -1.53 in the BCOP test. Therefore, the test item is not irritating to the eye (no category).
- Executive summary:
An in vitro (ex vivo) Bovine Corneal Opacity and Permeability study was conducted in order to determine the potential severe eye damaging effects of the test item according to the OECD guideline 437 under GLP conditions. Four sets consisting of three corneas each were tested: the first set was the negative control, and was treated with 750 μL normal saline; the second set was the positive control, and was treated with 750 μL of 20% (w/v) imidazole in normal saline; the third set was the solvent/vehicle control and was treated with 750 μL corn oil and the fourth set was treated with 750 μL of 20% (w/v) of test item suspension in corn oil for 4h at 32ºC. After exposure, opacity of the corneas was measured. Then, to determine permeability, 1 mL fluorescein solution (5 mg/mL) was applied on the anterior surface of the corneas, while fresh EMEM (phenol red-free) was added to the posterior chamber and, after 90 min incubation at 32ºC, the OD (490 nm) of the medium in the posterior chamber was measured. Acceptance criteria were met for positive, negative a solvent controls. The mean corneal opacity for the test item treated corneas was -1.45, the mean permeability was -0.005 and the mean IVIS score was found to be -1.53. Therefore, the test item is not irritating to the eye (no category).
Reference
Table 1. In vitro Irritation Score.
Group : Normal Saline, 0.75 mL |
|||||||||
Cornea Holder N° |
Io (LUX) |
I (Initial) (LUX) |
Initial Opacity Value |
I (Post Treatment) (LUX) |
Post Treatment Opacity Value |
Corr. Opacity Value |
OD490 Value |
Corr. OD490 Value |
IVIS |
2 |
1116 |
1027 |
3.87 |
1010 |
4.60 |
0.73 |
0.06 |
0.010 |
0.88 |
9 |
1101 |
1115 |
-0.08 |
1094 |
0.68 |
0.76 |
0.053 |
0.003 |
0.81 |
12 |
1136 |
1051 |
3.64 |
1003 |
5.71 |
2.07 |
0.063 |
0.013 |
2.27 |
Mean |
1.19 |
- |
0.009 |
1.32 |
|||||
SD |
0.77 |
- |
0.005 |
0.82 |
Group : Imidazole at 20% (w/v) in normal saline, 0.75 mL |
|||||||||||||||||
Cornea Holder N° |
Io (LUX) |
I (Initial) (LUX) |
Initial Opacity Value |
I (Post Treatment) (LUX) |
Post Treatment Opacity Value |
Corr. Opacity Value |
Final Opacity Value |
OD490 Value |
Corr. OD490Value |
Final OD490Value |
IVIS |
||||||
3 |
1106 |
970 |
6.01 |
383 |
75.63 |
69.62 |
68.43 |
2.124 |
2.074 |
2.065 |
99.41 |
||||||
6 |
1162 |
1141 |
1.16 |
337 |
97.96 |
96.80 |
95.61 |
1.858 |
1.808 |
1.799 |
122.60 |
||||||
10 |
1140 |
1134 |
0.63 |
320 |
102.51 |
101.88 |
100.69 |
2.23 |
2.18 |
2.171 |
133.26 |
||||||
Mean |
88.24 |
- |
2.021 |
2.012 |
118.42 |
||||||||||||
SD |
17.35 |
- |
0.192 |
0.192 |
17.31 |
||||||||||||
Group : Corn Oil, 0.75 mL |
|||||||||||||||||
Cornea Holder N° |
Io (LUX) |
I (Initial) (LUX) |
Initial Opacity Value |
I (Post Treatment) (LUX) |
Post Treatment Opacity Value |
Corr. Opacity Value |
OD490 Value |
Corr. OD490 Value |
IVIS |
||||||||
5 |
1132 |
1063 |
3.01 |
1002 |
5.59 |
2.58 |
0.068 |
0.018 |
2.85 |
||||||||
8 |
1159 |
1120 |
1.81 |
1085 |
3.14 |
1.33 |
0.061 |
0.011 |
1.50 |
||||||||
11 |
1127 |
1115 |
0.85 |
1106 |
1.18 |
0.33 |
0.064 |
0.014 |
0.54 |
||||||||
Mean |
1.41 |
- |
0.014 |
1.63 |
|||||||||||||
SD |
1.13 |
- |
0.004 |
1.16 |
Group : N,N’-(methylenedi-p-phenylene)bis(aziridine-1-carboxamide) (POLY-U-01) (suspension) at 20% (w/v) in Corn Oil, 0.75 mL |
|||||||||||
Cornea Holder N° |
Io (LUX) |
I (Initial) (LUX) |
Initial Opacity Value |
I (Post Treatment) (LUX) |
Post Treatment Opacity Value |
Corr. Opacity Value |
Final Opacity Value |
OD490 Value |
Corr. OD490 Value |
Final OD490 Value |
IVIS |
1 |
1129 |
1088 |
1.92 |
1108 |
1.18 |
-0.74 |
-2.15 |
0.059 |
0.009 |
-0.005 |
-2.23 |
7 |
1162 |
1078 |
3.53 |
1080 |
3.45 |
-0.08 |
-1.49 |
0.058 |
0.008 |
-0.006 |
-1.58 |
13 |
1182 |
1113 |
2.89 |
1095 |
3.59 |
0.70 |
-0.71 |
0.06 |
0.01 |
-0.004 |
-0.77 |
Mean |
-1.45 |
- |
0.009 |
-0.005 |
-1.53 |
||||||
SD |
0.72 |
- |
0.001 |
0.001 |
0.73 |
Keys: IVIS = In Vitro Irritation Score, Io =Baseline Reading (With medium but without cornea), I = LUX Reading with Medium and Cornea, OD490= Optical Density at 490 Wave Length, - = Not Applicable, Corr. = Corrected. Blank OD490value = 0.050.
- InitialOpacity Value = [((Io⁄I)-b)/a)], Where I = Initial LUX, Io = Baseline Reading, Note: a (0.0251) and b (0.9894) are constant.
- Post TreatmentOpacity Value = [((Io⁄I)-b)/a)], Where, I = Post Treatment LUX, Io = Baseline Reading. Note: a (0.0251) and b (0.9894) are constant.
- Corr. Opacity Value = Post Treatment Opacity Value - Initial Opacity Value
- Final Opacity Value = Corr. Opacity Value – Mean Corr. Opacity Value of Control (Group I)
- Corr. OD490Value = OD490Value – Blank OD490Value, Where Blank Value for this trial was 0.050
- Final OD490Value = Corr. OD490Value –Mean Corr.OD490Valueof Control (Group I)
- IVIS (Control) = Corr. Opacity Value + (15 x Corrected OD490)
- IVIS (Treatment) = Final Opacity Value + (15 x Final OD490)
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation. Key study. An in vitro skin irritation test of the test item was performed in a reconstructed human SkinEthic RHE®model, according to OECD TG 439 (GLP study). Three epidermis units were treated with 16 mg test item for 42 minutes at room temperature. Exposure of the test item was terminated by rinsing with 25 x 1 mL of DPBS. The epidermis units were then incubated at 37°C for 42 hours in an incubator with 5% CO2. The viability of each disk was assessed by incubating the tissues with MTT, extracting the precipitated formazan crystals using isopropanol and incubating the tissues for overnight in a refrigerator protected from light, and finally measuring the concentration of formazan by determining the OD at 570 nm. Under the test conditions, the mean percent viability of the treated tissues was 93.1%, versus 1.2% of the positive control (5% Sodium Dodecyl Sulfate). Therefore, the test item must be considered as not classified for skin irritation.
Eye irritation. Key study. An in vitro (ex vivo) Bovine Corneal Opacity and Permeability study was conducted in order to determine the potential severe eye damaging effects of the test item according to the OECD guideline 437 under GLP conditions. Four sets consisting of three corneas each were tested: the first set was the negative control, and was treated with 750 μL normal saline; the second set was the positive control, and was treated with 750 μL of 20% (w/v) imidazole in normal saline; the third set was the solvent/vehicle control and was treated with 750 μL corn oil and the fourth set was treated with 750 μL of 20% (w/v) of test item suspension in corn oil for 4h at 32ºC. After exposure, opacity of the corneas was measured. Then, to determine permeability, 1 mL fluorescein solution (5 mg/mL) was applied on the anterior surface of the corneas, while fresh EMEM (phenol red-free) was added to the posterior chamber and, after 90 min incubation at 32ºC, the OD (490 nm) of the medium in the posterior chamber was measured. Acceptance criteria were met for positive, negative a solvent controls. The mean corneal opacity for the test item treated corneas was -1.45, the mean permeability was -0.005 and the mean IVIS score was found to be -1.53. Therefore, the test item is not irritating to the eye (no category).
Justification for classification or non-classification
Based on the available information, the test item is not classified for skin irritation/corrosion in accordance with CLP Regulation (EU) No. 1272/2008.
Based on the available information, the test item is not classified for serious eye damage/eye irritation in accordance with CLP Regulation (EU) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)